日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and prognostic model development of immune checkpoint inhibitor rechallenge in recurrent or metastatic nasopharyngeal carcinoma: a real-world study

免疫检查点抑制剂再次治疗复发或转移性鼻咽癌的疗效及预后模型构建:一项真实世界研究

Jiang, Yaofei; Wu, Jie; Dong, Shuhui; Zhang, Zhenyu; Bei, Weixin; Zheng, Lisheng; Xiang, Yanqun; Liu, Guoying

Efficacy and safety of cadonilimab (PD-1/CTLA-4 bispecific) in combination with chemotherapy in anti-PD-1-resistant recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase 2 trial

卡多尼利单抗(PD-1/CTLA-4双特异性抗体)联合化疗治疗抗PD-1耐药的复发性或转移性鼻咽癌的疗效和安全性:一项单臂、开放标签的II期试验

Jiang, Yaofei; Bei, Weixin; Wang, Lin; Lu, Nian; Xu, Cheng; Liang, Hu; Ke, Liangru; Ye, Yanfang; He, Shuiqing; Dong, Shuhui; Liu, Qin; Zhang, Chuanrun; Wang, Xuguang; Xia, Weixiong; Zhao, Chong; Huang, Ying; Xiang, Yanqun; Liu, Guoying

Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors

既往接受过化疗和PD-1抑制剂治疗的转移性鼻咽癌患者二线治疗中再次使用PD-1抑制剂的疗效和安全性

Bei, Weixin; Dong, Shuhui; Liu, Guoying; Lin, Lanfeng; Jiang, Yaofei; Lu, Nian; Li, Wangzhong; Liang, Hu; Xiang, Yanqun; Xia, Weixiong

Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma

Epstein-Barr病毒DNA血清阳性与鼻咽癌中独特的肿瘤异质性和免疫微环境相关

Li, Wangzhong; Lv, Shuhui; Liu, Guoying; Lu, Nian; Jiang, Yaofei; Liang, Hu; Xia, Weixiong; Xiang, Yanqun; Xie, Changqing; He, Jianxing

Concurrent chemoradiotherapy combined with nimotuzumab in stage III-IVa nasopharyngeal carcinoma: a retrospective analysis

同步放化疗联合尼妥珠单抗治疗III-IVa期鼻咽癌:一项回顾性分析

Cai, Zhuochen; Chen, Dongni; Qiu, Wenze; Liang, Chixiong; Huang, Yingying; Zhou, Jiayu; Zhan, Zejiang; Xiang, Yanqun; Guo, Xiang; Lv, Xing

Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up

早期鼻咽癌患者接受调强放射治疗后的长期生存率、毒性反应及化疗的作用:一项为期15年的回顾性随访研究

Wang, Lin; Miao, Jingjing; Huang, Huageng; Chen, Boyu; Xiao, Xiao; Zhu, Manyi; Liang, Yingshan; Xiao, Weiwei; Huang, Shaomin; Peng, Yinglin; Deng, Xiaowu; Lv, Xing; Xia, Weixiong; Xiang, Yanqun; Guo, Xiang; Han, Fei; Zhao, Chong

Prognostic and Treatment Guiding Significance of MRI-Based Tumor Burden Features and Nodal Necrosis in Nasopharyngeal Carcinoma

MRI肿瘤负荷特征和淋巴结坏死在鼻咽癌预后和治疗指导中的意义

Chen, Xi; Cao, Xun; Jing, Bingzhong; Xia, Weixiong; Ke, Liangru; Xiang, Yanqun; Liu, Kuiyuan; Qiang, Mengyun; Liang, Chixiong; Li, Jianpeng; Gao, Mingyong; Li, Wangzhong; Miao, Jingjing; Liu, Guoying; Cai, Zhuochen; Lv, Shuhui; Guo, Xiang; Li, Chaofeng; Lv, Xing

Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.

基于 CRISPR 的全基因组基因敲除筛选揭示了鼻咽癌所必需的细胞因子和通路

Wang Chong, Jiang Sizun, Ke Liangru, Zhang Luyao, Li Difei, Liang Jun, Narita Yohei, Hou Isabella, Chen Chen-Hao, Wang Liangwei, Zhong Qian, Ling Yihong, Lv Xing, Xiang Yanqun, Guo Xiang, Teng Mingxiang, Tsao Sai-Wah, Gewurz Benjamin E, Zeng Mu-Sheng, Zhao Bo

Elevated Levels of TNF-α and Decreased Levels of CD68-Positive Macrophages in Primary Tumor Tissues Are Unfavorable for the Survival of Patients With Nasopharyngeal Carcinoma

原发肿瘤组织中TNF-α水平升高和CD68阳性巨噬细胞水平降低不利于鼻咽癌患者的生存。

Yu, Yahui; Ke, Liangru; Xia, Wei-Xiong; Xiang, Yanqun; Lv, Xing; Bu, Junguo

Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies

开发和验证基于内镜图像的深度学习模型用于检测鼻咽癌

Li, Chaofeng; Jing, Bingzhong; Ke, Liangru; Li, Bin; Xia, Weixiong; He, Caisheng; Qian, Chaonan; Zhao, Chong; Mai, Haiqiang; Chen, Mingyuan; Cao, Kajia; Mo, Haoyuan; Guo, Ling; Chen, Qiuyan; Tang, Linquan; Qiu, Wenze; Yu, Yahui; Liang, Hu; Huang, Xinjun; Liu, Guoying; Li, Wangzhong; Wang, Lin; Sun, Rui; Zou, Xiong; Guo, Shanshan; Huang, Peiyu; Luo, Donghua; Qiu, Fang; Wu, Yishan; Hua, Yijun; Liu, Kuiyuan; Lv, Shuhui; Miao, Jingjing; Xiang, Yanqun; Sun, Ying; Guo, Xiang; Lv, Xing